RPL8 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.882400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.378800E-01
Normal-vs-Stage2
4.963400E-01
Normal-vs-Stage3
9.043800E-01
Normal-vs-Stage4
3.073200E-01
Stage1-vs-Stage2
6.894800E-01
Stage1-vs-Stage3
7.872200E-01
Stage1-vs-Stage4
7.140600E-01
Stage2-vs-Stage3
5.072400E-01
Stage2-vs-Stage4
9.200000E-01
Stage3-vs-Stage4
4.069200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.668000E-01
Normal-vs-AfricanAmerican
9.059000E-01
Normal-vs-Asian
5.272200E-01
Caucasian-vs-AfricanAmerican
3.602600E-03
Caucasian-vs-Asian
6.298000E-01
AfricanAmerican-vs-Asian
2.121800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.340800E-01
Normal-vs-Female
5.705200E-01
Male-vs-Female
7.113700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.679200E-01
Normal-vs-Age(41-60Yrs)
4.890600E-01
Normal-vs-Age(61-80Yrs)
4.951400E-01
Normal-vs-Age(81-100Yrs)
3.123000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.57572999999189E-05
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.13829999870418E-08
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.710400E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.687000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.482390E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.558620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.207600E-01
Normal-vs-Daily Drinker
3.860200E-01
Normal-vs-Weekly Drinker
5.984400E-01
Normal-vs-Occasional Drinker
1.349160E-01
Normal-vs-Social Drinker
8.137800E-01
Non Drinker-vs-Daily Drinker
2.369800E-01
Non Drinker-vs-Weekly Drinker
7.183000E-01
Non Drinker-vs-Occasional Drinker
1.115790E-01
Non Drinker-vs-Social Drinker
3.617600E-01
Daily Drinker-vs-Weekly Drinker
6.182200E-01
Daily Drinker-vs-Occasional Drinker
9.795600E-01
Daily Drinker-vs-Social Drinker
7.236100E-02
Weekly Drinker-vs-Occasional Drinker
5.948600E-01
Weekly Drinker-vs-Social Drinker
3.852000E-01
Occasional Drinker-vs-Social Drinker
1.751840E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.695600E-01
Normal-vs-Grade 2
7.469000E-01
Normal-vs-Grade 3
6.230600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.461200E-01
Grade 1-vs-Grade 3
3.442200E-01
Grade 1-vs-Grade 4
7.695600E-01
Grade 2-vs-Grade 3
1.496380E-01
Grade 2-vs-Grade 4
7.469000E-01
Grade 3-vs-Grade 4
6.230600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.312600E-01
Normal-vs-NonDiabetic
4.841600E-01
Diabetic-vs-NonDiabetic
9.741200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.343200E-01
Normal-vs-NoPancreatitis
4.608800E-01
Pancreatitis-vs-NoPancreatitis
7.236400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.308000E-01
Normal-vs-N1
5.430600E-01
N0-vs-N1
5.258400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.823200E-01
Normal-vs-TP53-NonMutant
7.927400E-01
TP53-Mutant-vs-TP53-NonMutant
1.536410E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
